Lagoda Investment Management as of Sept. 30, 2016
Portfolio Holdings for Lagoda Investment Management
Lagoda Investment Management holds 29 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seattle Genetics | 9.2 | $31M | 567k | 54.01 | |
| Regeneron Pharmaceuticals (REGN) | 8.8 | $29M | 73k | 402.02 | |
| Renaissance Re Holdings Ltd Cmn (RNR) | 7.5 | $25M | 209k | 120.16 | |
| Digimarc Corporation (DMRC) | 7.5 | $25M | 652k | 38.35 | |
| Ptc (PTC) | 6.8 | $23M | 509k | 44.31 | |
| Ubiquiti Networks | 6.6 | $22M | 410k | 53.50 | |
| Alphabet Inc Class C cs (GOOG) | 6.5 | $22M | 28k | 777.32 | |
| Senomyx | 6.2 | $21M | 4.8M | 4.26 | |
| Alexion Pharmaceuticals | 5.8 | $19M | 158k | 122.54 | |
| Novo Nordisk A/S (NVO) | 5.8 | $19M | 460k | 41.59 | |
| Monsanto Company | 5.4 | $18M | 175k | 102.20 | |
| Volitionrx (VNRX) | 4.7 | $16M | 2.9M | 5.30 | |
| T2 Biosystems | 4.1 | $14M | 1.9M | 7.24 | |
| Intrexon | 4.0 | $14M | 480k | 28.02 | |
| Merrimack Pharmaceuticals In | 3.6 | $12M | 1.9M | 6.35 | |
| Baidu (BIDU) | 2.9 | $9.8M | 54k | 182.07 | |
| Alphabet Inc Class A cs (GOOGL) | 2.7 | $9.0M | 11k | 804.06 | |
| Enstar Group (ESGR) | 1.0 | $3.2M | 20k | 164.48 | |
| MasterCard Incorporated (MA) | 0.6 | $1.8M | 18k | 101.76 | |
| Berkshire Hathaway (BRK.A) | 0.1 | $432k | 2.00 | 216000.00 | |
| Berkshire Hathaway (BRK.B) | 0.1 | $202k | 1.4k | 144.29 | |
| Alleghany Corporation | 0.0 | $142k | 270.00 | 525.93 | |
| Exxon Mobil Corporation (XOM) | 0.0 | $62k | 715.00 | 86.71 | |
| Pfizer (PFE) | 0.0 | $50k | 1.5k | 33.85 | |
| ConocoPhillips (COP) | 0.0 | $54k | 1.2k | 43.87 | |
| Abbott Laboratories (ABT) | 0.0 | $27k | 640.00 | 42.19 | |
| Abbvie (ABBV) | 0.0 | $31k | 491.00 | 63.14 | |
| GlaxoSmithKline | 0.0 | $8.0k | 174.00 | 45.98 | |
| Phillips 66 (PSX) | 0.0 | $16k | 197.00 | 81.22 |
